Arcus Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Arcus Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Arcus Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $233M, a 55.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $233M +$83M +55.3% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $150M +$67M +80.7% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $83M -$1.23M -1.46% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $84.2M +$33.8M +67.1% Dec 31, 2020 10-K 2022-02-23
Q4 2019 $50.4M +$19.7M +64% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $30.7M +$12.2M +65.4% Dec 31, 2018 10-K 2020-03-05
Q4 2017 $18.6M Dec 31, 2017 10-K 2019-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.